Search research articles
Contact Us
Filters
Showing results (131-140 of 200) with videos related to
Page
of 20
Sort By:
European Heart Journal. Acute Cardiovascular Care
|
December 26, 2025
Guided De-escalation of Antiplatelet Treatment in Patients at High Atherothrombotic Risk Presenting With Acute Coronary Syndrome: A Post-Hoc Analysis of the TROPICAL-ACS trial
Serdar Farhan, Ralph Hein, Dietmar Trenk, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
February 13, 2020
Antithrombotic therapy in patients with acute coronary syndrome complicated by cardiogenic shock or out-of-hospital cardiac arrest: a joint position paper from the European Society of Cardiology (ESC) Working Group on Thrombosis, in association with the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Diana A Gorog, Susanna Price, Dirk Sibbing, et al.
Circulation. Cardiovascular Interventions
|
June 13, 2020
Randomized Comparison of Intensified and Standard P2Y<sub>12</sub>-Receptor-Inhibition Before Elective Percutaneous Coronary Intervention: The SASSICAIA Trial
Julinda Mehilli, Moritz Baquet, Willibald Hochholzer, et al.
JACC. Asia
|
June 12, 2026
Clopidogrel Vs Aspirin Monotherapy for Secondary Prevention After Percutaneous Coronary Intervention: A Nationwide Cohort Study
Jun Hwan Cho, Seng Chan You, Hoseob Kim, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
December 20, 2019
Smoking and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients: a substudy from the randomized TROPICAL-ACS trial
Martin Orban, Dietmar Trenk, Tobias Geisler, et al.
European Heart Journal
|
July 19, 2021
Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy
Victor Aboyans, Rupert Bauersachs, Lucia Mazzolai, et al.
Journal of the American College of Cardiology
|
April 25, 2015
Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation: The ISAR-TRIPLE Trial
Katrin A Fiedler, Michael Maeng, Julinda Mehilli, et al.
American Heart Journal
|
September 3, 2011
Impact of smoking on antiplatelet effect of clopidogrel and prasugrel after loading dose and on maintenance therapy
Willibald Hochholzer, Dietmar Trenk, Jessica L Mega, et al.
Thrombosis and Haemostasis
|
August 18, 2019
Thrombogenicity and Antithrombotic Strategies in Structural Heart Interventions and Nonaortic Cardiac Device Therapy-Current Evidence and Practice
Tobias Geisler, Rezo Jorbenadze, Aron-Frederik Popov, et al.
European Heart Journal
|
May 19, 2026
Aspirin vs clopidogrel in chronic coronary syndromes: a meta-analysis of ethnic differences
Claudio Laudani, Giovanni Occhipinti, Francesco Costa, et al.
Page
of 20
Search research articles
Search
Showing results (131-140 of 200) with videos related to
Sort By:
Page
of 20
European Heart Journal. Acute Cardiovascular Care
|
December 26, 2025
Guided De-escalation of Antiplatelet Treatment in Patients at High Atherothrombotic Risk Presenting With Acute Coronary Syndrome: A Post-Hoc Analysis of the TROPICAL-ACS trial
Serdar Farhan, Ralph Hein, Dietmar Trenk, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
February 13, 2020
Antithrombotic therapy in patients with acute coronary syndrome complicated by cardiogenic shock or out-of-hospital cardiac arrest: a joint position paper from the European Society of Cardiology (ESC) Working Group on Thrombosis, in association with the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Diana A Gorog, Susanna Price, Dirk Sibbing, et al.
Circulation. Cardiovascular Interventions
|
June 13, 2020
Randomized Comparison of Intensified and Standard P2Y<sub>12</sub>-Receptor-Inhibition Before Elective Percutaneous Coronary Intervention: The SASSICAIA Trial
Julinda Mehilli, Moritz Baquet, Willibald Hochholzer, et al.
JACC. Asia
|
June 12, 2026
Clopidogrel Vs Aspirin Monotherapy for Secondary Prevention After Percutaneous Coronary Intervention: A Nationwide Cohort Study
Jun Hwan Cho, Seng Chan You, Hoseob Kim, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
December 20, 2019
Smoking and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients: a substudy from the randomized TROPICAL-ACS trial
Martin Orban, Dietmar Trenk, Tobias Geisler, et al.
European Heart Journal
|
July 19, 2021
Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy
Victor Aboyans, Rupert Bauersachs, Lucia Mazzolai, et al.
Journal of the American College of Cardiology
|
April 25, 2015
Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation: The ISAR-TRIPLE Trial
Katrin A Fiedler, Michael Maeng, Julinda Mehilli, et al.
American Heart Journal
|
September 3, 2011
Impact of smoking on antiplatelet effect of clopidogrel and prasugrel after loading dose and on maintenance therapy
Willibald Hochholzer, Dietmar Trenk, Jessica L Mega, et al.
Thrombosis and Haemostasis
|
August 18, 2019
Thrombogenicity and Antithrombotic Strategies in Structural Heart Interventions and Nonaortic Cardiac Device Therapy-Current Evidence and Practice
Tobias Geisler, Rezo Jorbenadze, Aron-Frederik Popov, et al.
European Heart Journal
|
May 19, 2026
Aspirin vs clopidogrel in chronic coronary syndromes: a meta-analysis of ethnic differences
Claudio Laudani, Giovanni Occhipinti, Francesco Costa, et al.
Page
of 20